Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, 2725 Chemin Sainte-Foy, Québec, QC, Canada G1V 4G5.
Respir Med. 2011 Jan;105(1):8-14. doi: 10.1016/j.rmed.2010.07.022. Epub 2010 Aug 24.
We describe a new tool, the Physicians' Practice Assessment Questionnaire (PPAQ), designed for the global self-assessment of implementation of asthma and COPD guidelines, as determined by the percentage of patients in whom physicians estimate that they implement guidelines key recommendations. Some of its properties were assessed by a group of 47 general practitioners (GPs), and test-retest data were obtained in repeating the questionnaire at a 5-week interval without intervention in a sub-group of 28 practitioners. Answers to the various questions were globally reproducible. The lowest scores (recommendations implemented in less than 50% of their patients) were: 1) for both asthma and COPD: referral for patient education, provision of a written action plan and regular assessment of inhaler technique, 2) for asthma: referral to a specialist for difficult to control asthma or uncertain diagnosis, and 3) for COPD: assessment of lung function and disability according to specific criteria and referral to a rehabilitation program. The analysis showed sufficient internal consistency for both questionnaires (Cronbach alphas 0.7617 for asthma and 0.8317 for COPD). Pearson's correlations indicated good test-retest (r = 0.6421, p = 0.0002 for asthma; r = 0.6801, p < 0.0001 for COPD). In conclusion, the PPAQ is a new tool to assess implementation of asthma and COPD guidelines; it has the potential to identify care gaps that can be specifically targeted for intervention.
我们描述了一种新工具,即医生实践评估问卷(PPAQ),旨在通过医生估计他们实施指南关键建议的患者比例,对全球范围内的哮喘和 COPD 指南实施情况进行自我评估。该问卷的一些特性由 47 名全科医生(GP)进行了评估,并在没有干预的情况下,对 28 名医生中的亚组进行了 5 周间隔的重复问卷调查,获得了测试 - 重测数据。各种问题的答案具有全球可重复性。得分最低(在不到 50%的患者中实施的建议)的是:1)哮喘和 COPD 均:将患者转介进行教育、提供书面行动计划和定期评估吸入器技术,2)哮喘:将难以控制的哮喘或诊断不确定的患者转介给专家,3)COPD:根据特定标准评估肺功能和残疾,并将患者转介到康复计划。分析表明两个问卷都具有足够的内部一致性(哮喘问卷的 Cronbach α 为 0.7617,COPD 问卷为 0.8317)。Pearson 相关分析表明测试 - 重测结果良好(哮喘 r = 0.6421,p = 0.0002;COPD r = 0.6801,p < 0.0001)。总之,PPAQ 是一种评估哮喘和 COPD 指南实施情况的新工具;它有可能确定可以针对性干预的护理差距。